Birgit Stattin Norinder

Birgit Stattin Norinder currently serves as Director at Wingfirm Pharma AB since 2014, Director at Jettesta AB since 2011, Director at Navigation Dynamics AB, and Independent Director at Nanexa AB since 2021.
Former roles include President & Chief Executive Officer at deCODE genetics, Inc. from 2006 to 2009, Chairman & Chief Executive Officer at Prolifix Ltd. from 1998 to 2002, Chairman & Chief Executive Officer at Lauras AS, Chairman at Flerie AB, Chairman at Hansa Biopharma AB from 2014 to 2016, Director at Probi AB, Independent Director at Nicox SA from 2011 to 2018, Independent Director at Karo Healthcare AB, Director at Photocure ASA, Independent Non-Executive Director at Sarossa Capital Ltd. from 2010 to 2011, Director at Artimplant AB, Director at MiniDoc AB, Director at Biolipox AB, Director at Vivesto AB from 2020 to 2022, Director-International Regulatory Affairs at Glaxo Group Research Ltd., Director at EXINI Diagnostics AB, Director at Wntresearch AB, Director at NeoDynamics AB, Principal at Pfizer Inc., Board member at Aqilion AB from 2010 to 2017, Vice President-Infection Research & Development at Astra Research Centre AB, Vice President-Infection Research & Development at Parke-Davis AB, and Senior VP-Worldwide Product Development at Pharmacia & Upjohn AB. Education includes undergraduate and graduate degrees from the University of Uppsala.